Cardiac monitoring

New Study Published in JACC Clinical EP Validates that Cardiologs' AI Eliminates Nearly Two-Thirds of False Positives in Remote Monitoring for Atrial Fibrillation

Retrieved on: 
Wednesday, February 10, 2021
Medicine, Branches of biology, Cardiac electrophysiology, Clinical medicine, Atrial fibrillation, Cardiac monitoring, Implantable loop recorder, Monitoring, Electrocardiography, ILR

The findings show that Cardiologs' AI-based ECG analysis solution significantly reduces the rate of false positive atrial fibrillation (AFib) detection in remote cardiac monitoring of patients with implantable loop recorders (ILRs).

Key Points: 
  • The findings show that Cardiologs' AI-based ECG analysis solution significantly reduces the rate of false positive atrial fibrillation (AFib) detection in remote cardiac monitoring of patients with implantable loop recorders (ILRs).
  • Cardiologs and Valley Health tracked a cohort of 425 patients who received an ILR for known AFib or cryptogenic stroke.
  • Since ILRs transmit data daily, these false positives are one of the Achilles heels of remote cardiac monitoring.
  • Publication of our successful trial results in JACC EP further validates the considerable promise of our solution for the clinical community.

Worldwide Cardiac Monitoring & Cardiac Rhythm Management Industry to 2027 - by End-user, Product and Geography

Retrieved on: 
Thursday, February 4, 2021
Cardiac electrophysiology, Medical emergencies, Branches of biology, Cardiac monitoring, Medical monitoring, Arrhythmia, Heart, Physiology, Cardiac arrhythmia, Cardiac arrest

DUBLIN, Feb. 4, 2021 /PRNewswire/ -- The "Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 4, 2021 /PRNewswire/ -- The "Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Cardiac Monitoring & Cardiac Rhythm Management market accounted for $25,152.56 million in 2019 and is expected to reach $48,665.45 million by 2027 growing at a CAGR of 8.6% during the forecast period.
  • Cardiac rhythm management maintains a normal cardiac rhythm in patients suffering from irregular heart rate and rhythm disorder.
  • The cardiac monitoring & cardiac rhythm management include devices that help the patients to manage and treat arrhythmia-related diseases.

Pylo Launches 4G Blood Pressure Monitor for Remote Patient Monitoring

Retrieved on: 
Wednesday, February 3, 2021
Medical specialties, Medical monitoring, Medicine, Branches of biology, Anesthesia, Intensive care medicine, Monitoring, Nanomedicine, Cardiac monitoring

LOS ANGELES, Feb. 3, 2021 /PRNewswire/ --Pylo Health proudly announced today the release of the Pylo 802-LTE, a cellular blood pressure monitor designed for patients undergoing remote physiological monitoring (RPM).

Key Points: 
  • LOS ANGELES, Feb. 3, 2021 /PRNewswire/ --Pylo Health proudly announced today the release of the Pylo 802-LTE, a cellular blood pressure monitor designed for patients undergoing remote physiological monitoring (RPM).
  • While operating like a traditional blood pressure monitor to patients, the 802-LTE quickly captures and transmits accurate blood pressure and heart rate measurements via encrypted 4G wireless sync to the intuitive Pylo application programming interface (API).
  • "Many patients who need to monitor their blood pressure are not tech savvy," says Daniel Tashnek, founder of Pylo and Prevounce Health.
  • "Research has shown that remote cardiac monitoring can greatly reduce patient blood pressure compared to typical care and self-monitoring alone," Tashnek says.

Global Cardiac Monitoring & Cardiac Rhythm Management Market Outlook to 2027 - Players Include Stryker, St. Jude Medical and Siemens Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 3, 2021
Medical devices, Health, Cardiac electrophysiology, Medical emergencies, Branches of biology, Cardiac monitoring, Medical monitoring, Arrhythmia, Cardiac arrhythmia, Cardiac arrest

The "Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Cardiac Monitoring & Cardiac Rhythm Management market accounted for $25,152.56 million in 2019 and is expected to reach $48,665.45 million by 2027 growing at a CAGR of 8.6% during the forecast period.
  • Cardiac rhythm management maintains a normal cardiac rhythm in patients suffering from irregular heart rate and rhythm disorder.
  • The cardiac monitoring & cardiac rhythm management include devices that help the patients to manage and treat arrhythmia-related diseases.

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against iRhythm Technologies, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, February 2, 2021
Legal, Professional services, Healthcare reform in the United States, Federal assistance in the United States, Liberalism in the United States, Medicare, Presidency of Lyndon B. Johnson, Cardiac monitoring, United States

Investors have until April 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until April 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • iRhythm offers a portfolio of ambulatory cardiac monitoring services on its platform, called the Zio service.
  • On January 29, 2021, Medicare Administrative Contractor Novitas Solutions published actual reimbursement rates under the CMS 2021 Medicare Physician Fee Schedule.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Worldwide Wireless ECG Devices Industry to 2025 - Declining Cost of Wireless Technologies is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, February 1, 2021
Medical devices, Health, Mobile, Wireless, Technology, Cardiology, Medicine, Clinical medicine, Branches of biology, Cardiac electrophysiology, Electrodiagnosis, Medical monitoring, Heart diseases, Electrocardiography, Electrophysiology, Cardiac monitoring, Monitoring, Cardiovascular disease

Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

Key Points: 
  • Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.
  • Increasing awareness regarding early detection and management of cardiovascular diseases is augmenting the demand for continuous cardiovascular ECG monitoring devices.
  • The development of commercially advanced devices, with enabled Bluetooth sensor technology and mobile app technology, is anticipated to drive the popularity of continuous cardiovascular ECG monitoring systems.
  • The United States holds the largest market share in the North American wireless ECG devices market, and it is expected to register a high growth rate over the forecast period.

AliveCor Now Detects Six Times as Many Cardiac Conditions as Any Other Personal ECG

Retrieved on: 
Monday, February 1, 2021
Branches of biology, Medicine, Medical technology, Cardiac electrophysiology, Cardiac arrhythmia, Medical devices, Alivecor, Electrocardiography, Cardiac monitoring, Tachycardia, Atrial fibrillation, Wireless ambulatory ECG

MOUNTAIN VIEW, Calif., Feb. 1, 2021 /PRNewswire/ -- AliveCor , the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today launched an expanded range of ECG determinations on its KardiaMobile devices.

Key Points: 
  • MOUNTAIN VIEW, Calif., Feb. 1, 2021 /PRNewswire/ -- AliveCor , the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today launched an expanded range of ECG determinations on its KardiaMobile devices.
  • KardiaMobile devices already detect Atrial Fibrillation, Bradycardia, and Tachycardia, making six total heart conditions these devices can identify.
  • "This is a turning point in remote cardiac monitoringno other personal ECG in the world can offer this range of determinations and this level of accuracy," said Dr. Dave Albert, Chief Medical Officer at AliveCor.
  • AliveCor is a privately-held company headquartered in Mountain View, Calif. "Consumer" or "Personal" ECGs are ECG devices available for direct sale to consumers.

Global Cardiac Monitoring Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, January 29, 2021
Health, Medical devices, Cardiology, Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Electrocardiography, Cardiac monitoring, Monitoring, Heart, Wireless ambulatory ECG

The increase in the incidence of cardiovascular diseases (CVD) necessitates the need for long-term ECG monitoring.

Key Points: 
  • The increase in the incidence of cardiovascular diseases (CVD) necessitates the need for long-term ECG monitoring.
  • There are two different types of ECG monitors available in the market, namely monitoring ECG systems and diagnostic ECG systems.
  • North American holds the leading position in the cardiac monitoring market.
  • Furthermore, continuous advancements in the technology, growing awareness in patients about cardiac monitoring, well-established healthcare infrastructure, and favorable reimbursement policies are expected to boost the cardiac monitoring market in the North America region.

Veteran Cardiology Medtech Executive Tim O'Malley Joins iMedrix Mobile Cardiology as CEO

Retrieved on: 
Friday, January 29, 2021
Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Cardiac monitoring, O'Malley, Electrocardiography, Monitoring

MILPITAS, Calif., Jan. 29, 2021 /PRNewswire/ --Tim O'Malley, has joined iMedrixInc.manufacturer of KardioScreen, the world's first medical-grade mobile cardiac monitoring device, as its new Chief Executive Officer.

Key Points: 
  • MILPITAS, Calif., Jan. 29, 2021 /PRNewswire/ --Tim O'Malley, has joined iMedrixInc.manufacturer of KardioScreen, the world's first medical-grade mobile cardiac monitoring device, as its new Chief Executive Officer.
  • Mr. O'Malley joins the firm from EarlySense Inc., where he was their President and Chief Growth Officer.
  • "We are pleased to welcome Tim O'Malley to iMedrix at this important time in our history.
  • "With a truly Mobile ECG Platform, there is the ability to capture diagnostic grade ECGs almost anywhere and by anyone, "said Jadcherla.

VivaQuant Introduces Smallest One-Piece Mobile Cardiac Telemetry Device

Retrieved on: 
Thursday, January 28, 2021
Health, Medical devices, Cardiology, Medicine, Branches of biology, Clinical medicine, Cardiac electrophysiology, Medical emergencies, Medical monitoring, Cardiac monitoring, Electrocardiography, Arrhythmia, Heart, Monitoring, Telemetry

VivaQuant , a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, is proud to announce launch of the RX-1 mini.

Key Points: 
  • VivaQuant , a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, is proud to announce launch of the RX-1 mini.
  • The mini is the smallest one-piece mobile cardiac telemetry device on the market, setting a new standard for patient comfort and simplicity of use.
  • This results in lower operating costs and crisp high-clarity ECGs that can enable faster diagnosis for patients with cardiac disease.
  • VivaQuant is a digital health company providing remote cardiac monitoring services under the Rhythm ExpressTM brand.